Concepedia

Magdalena Sztachelska

MS

1

Publications

10

Citations

1

H-Index

2024

Active since

Affiliations

AstraZeneca (United States)(Current)

Magdalena Sztachelska is an author at AstraZeneca (United States).

Publications per year

2024–2024

1

Publications

1

Phase 1b/2, open-label dose-escalation and -expansion study evaluating trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with HER2+ and HER2-low gastric cancer (GC): DESTINY-Gastric03 (DG-03).

Yelena Y. Janjigian, Saeed Raoufmoghaddam, Magdalena Sztachelska et al. · Journal of Clinical Oncology · 2024 · 10 citations

Rows per page

1–1 of 1